参考文献/References:
[1] Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association[J].Gastroenterology,2012,142(7):1592-1609.
[2] Li L,Zhang L,Pan S,et al.No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population[J].Dig Dis Sci,2013,58(8):2376-2382.
[3] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):161-163.
[4] Targher G,Bertolini L,Scala L,et al.Associations between serum 25-hydroxyvitamin D concentrations and liver histology in patients with non-alcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis,2007,17(7):517-524.
[5] Manco M,Ciampalini P,Nobili V.Low levels of 25-hydroxyvitamin D3 in children with biopsy-proven nonalcoholic fatty liver disease[J].Hepatology,2010,51(6):2229.
[6] Barchetta I,Angelico F,Ben M,et al.Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes [J].BMC Med,2011,9:85.
[7] Katz K,Brar PC,Parekh N,et al.Suspected nonalcoholic fatty liver disease is not associated with vitamin D status in adolescents after adjustment for obesity[J].J Obes,2010,2010:496829.
[8] Eliades M,Spyrou E,Agrawal N,et al.Meta-analysis:vitamin D and non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther,2013,38(3):246-254.
[9] Donnelly KL,Smith CI,Schwarzenberg SJ,et al.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease[J].J Clin Invest,2005,115(5):1343-1351.
[10] Schmidt DR,Holmstrom SR,Fon Tacer K,et al.Regulation of bile acid synthesis by fat-soluble vitamins A and D[J]. J Biol Chem,2010,285(19):14486-14494.
[11] Chen X, Chen F, Liu S, et al. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor[J].Mol Pharmacol,2006,69(6):1913-1923.
[12] Thummel KE,Brimer C,Yasuda K,et al.Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3[J].Mol Pharmacol,2001,60(6):1399-1406.
[13] Bechmann LP,Hannivoort RA,Gerken G,et al.The interaction of hepatic lipid and glucose metabolism in liver diseases[J].J Hepatol,2012,56(4):952-964.
[14] Day CP.From fat to inflammation[J].Gastroenterology,2006,130(1):207-210.
[15] Arkan MC,Hevener AL,Greten FR,et al.IKK-beta links inflammation to obesity-induced insulin resistance[J].Nat med,2005,11(2):191-198.
[16] Chiu KC,Chu A,Go VL,et al.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction[J].Am J Clin Nutr,2004,79(5):820-825.
[17] Deleskog A,Hilding A,Brismar K,et al.Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance[J].Diabetologia,2012,55(6):1668-1678.
[18] Husemoen LL, Thuesen BH, Fenger M,et al.Serum 25(OH)D and type 2 diabetes association in a general population:a prospective study[J].Diabetes Care,2012,35(8):1695-1700.
[19] 张贺吉,吴江锋,柳长柏,等.肝星状细胞的可塑性及其对肝纤维化的意义[J].世界华人消化杂志,2011,19(33):3415-3419.
[20] Abramovitch S,Dahan-Bachar L,Sharvit E,et al.Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats[J].Gut,2011,60(12):1728-1737.
[21] Potter JJ,Liu X,Koteish A,et al.1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1(Ⅰ)collagen expression and type Ⅰ collagen formation[J]. Liver Int,2013,33(5):677-686.
相似文献/References:
[1]曹涵,曲伸.过氧化物酶体增殖物活化受体与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
Cao Han,Qu Shen..Peroxisome proliferator-activated receptors and non-alcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
[2]曹雯,夏萍,范尧夫,等.内分泌疾病的神经肌肉表现[J].国际内分泌代谢杂志,2015,(02):133.[doi:10.3760/cma.j.issn.1673-4157.2015.02.017]
Cao Wen,Xia Ping,Fan Yaofu,et al.Neuromuscular manifestations of endocrine disorders[J].International Journal of Endocrinology and Metabolism,2015,(06):133.[doi:10.3760/cma.j.issn.1673-4157.2015.02.017]
[3]岑超平,陈晓,李冲,等.维生素D与糖尿病并发症[J].国际内分泌代谢杂志,2015,(03):199.[doi:10.3760/cma.j.issn.1673-4157.2015.03.016]
Cen Chaoping,Chen Xiao,Li Chong,et al.Vitamin D and diabetic complications[J].International Journal of Endocrinology and Metabolism,2015,(06):199.[doi:10.3760/cma.j.issn.1673-4157.2015.03.016]
[4]常爱玲,马中书,邱明才.糖皮质激素对肾上腺次全切大鼠维生素D代谢的影响[J].国际内分泌代谢杂志,2014,(04):229.[doi:10.3760/cma.j.issn.1673-4157.2014.04.004]
Chang Ailing,Ma Zhongshu,Qiu Mingcai..Effects of glucocorticoid on vitamin D metabolism in subtotal adrenalectomized rats[J].International Journal of Endocrinology and Metabolism,2014,(06):229.[doi:10.3760/cma.j.issn.1673-4157.2014.04.004]
[5]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(06):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[6]张洁,邸阜生.运动防治非酒精性脂肪性肝病的机制[J].国际内分泌代谢杂志,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
Zhang Jie,Di Fusheng..Mechanism of exercise on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
[7]张雅楠,郗光霞,杨翠萍,等.自噬在非酒精性脂肪性肝病中的变化及作用[J].国际内分泌代谢杂志,2017,37(01):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
Zhang Yanan*,Xi Guangxia,Yang Cuiping,et al.The change and function of autophagy in nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
[8]李博,苏青.晚期糖基化终末产物及其受体与非酒精性脂肪性肝病的
关系[J].国际内分泌代谢杂志,2017,37(03):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
Li Bo,Su Qing..Relationship between advanced glycation end-products and its receptor in nonalcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2017,37(06):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
[9]狄红杰,刘超.饮食干预对非酒精性脂肪性肝病肠道菌群的影响[J].国际内分泌代谢杂志,2017,37(04):254.
Di Hongjie,Liu Chao..Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):254.
[10]林楚曼 林伟浩 周蕊 杨力.GLP-1缓解非酒精性脂肪性肝病相关信号通路的研究进展[J].国际内分泌代谢杂志,2018,38(03):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]
Lin Chuman*,Lin Weihao,Zhou Rui,et al.The research progresses on GLP-1 related signal pathways in alleviating non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]